Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03YIX
|
|||
| Former ID |
DIB015471
|
|||
| Drug Name |
Pneumostem
|
|||
| Indication | Respiratory distress syndrome [ICD-11: CB00; ICD-10: J80; ICD-9: 518.5, 518.82] | Phase 2 | [1] | |
| Bronchopulmonary dysplasia [ICD-11: KB29.0; ICD-10: P27.1; ICD-9: 770.7] | Phase 1/2 | [2] | ||
| Company |
Medipost Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01897987) Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM Phase-II Clinical Trial. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.